
MAZE vs NVAX
$MAZE vs $NVAX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
MAZE vs NVAX: the quick read
- ·MAZE is the larger company by market cap ($1.77B vs $1.73B).
- ·NVAX has been more active on our scanner (288 vs 78 alerts in 30 days).
- ·MAZE has the smaller float (52.8M vs 154.4M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·NVAX draws far more of our scanner's attention, 288 unusual-volume alerts in 30 days against 78, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
- ·NVAX pays a dividend and MAZE does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing MAZE and NVAX on TheDesperateTrader.
- Is MAZE or NVAX the better stock?
- "Better" depends on your goal, and these two are not alike. MAZE is the larger company by market cap ($1.77B vs $1.73B). NVAX has been more active on our scanner (288 vs 78 alerts in 30 days). MAZE has the smaller float (52.8M vs 154.4M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between MAZE and NVAX?
- The differences that matter: they are not in the same business - MAZE is biological products, (no diagnostic substances) and NVAX is biological products, (no diagnostic substances); they are similar in size ($1.77B vs $1.73B); they trade at very different share prices ($31.46 vs $10.04); MAZE sits at 30% of its 52-week range against 53% for NVAX; only NVAX pays a dividend; our scanner flagged MAZE 78 times in the last 30 days against 288 for NVAX. Everything above is measured from the latest completed session and SEC filings.
- Which of MAZE and NVAX is more active right now?
- Right now MAZE is at about 0.5x its normal volume and NVAX is at about 0.4x, so MAZE is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading MAZE or NVAX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore MAZE and NVAX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.